Mostrar el registro sencillo del ítem
Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix
dc.contributor.author | Hernández Fernaud, Juan Ramón | |
dc.contributor.author | Kay, Emily J. | |
dc.contributor.author | Paterson, Karla | |
dc.contributor.author | Riera-Domingo, Carla | |
dc.contributor.author | Sumpton, David | |
dc.contributor.author | Däbritz, J. Henry M. | |
dc.contributor.author | Tardito, Saverio | |
dc.contributor.author | Boldrini, Claudia | |
dc.contributor.author | Athineos, Dimitris | |
dc.contributor.author | Dhayade, Sandeep | |
dc.contributor.author | Stepanova, Ekaterina | |
dc.contributor.author | Gjerga, Enio | |
dc.contributor.author | Neilson, Lisa J. | |
dc.contributor.author | Lilla, Sergio | |
dc.contributor.author | Hedley, Ann | |
dc.contributor.author | Koulouras, Grigorios | |
dc.contributor.author | McGregor, Grace | |
dc.contributor.author | Jamieson, Craig | |
dc.contributor.author | Johnson, Radia Marie | |
dc.contributor.author | Park, Morag | |
dc.contributor.author | Kirschner, Kristina | |
dc.contributor.author | Miller, Crispin | |
dc.contributor.author | Kamphorst, Jurre J. | |
dc.contributor.author | Loayza-Puch, Fabricio | |
dc.contributor.author | Sáez-Rodríguez, Julio | |
dc.contributor.author | Mazzone, Massimiliano | |
dc.contributor.author | Blyth, Karen | |
dc.contributor.author | Zagnoni, Michele | |
dc.contributor.author | Zanivan, Sara | |
dc.contributor.other | Bioquímica, Microbiología, Biología Celular y Genética | |
dc.contributor.other | The Beatson Institute for Cancer Research, Glasgow, UK | |
dc.date.accessioned | 2024-09-23T20:08:28Z | |
dc.date.available | 2024-09-23T20:08:28Z | |
dc.date.issued | 2022 | |
dc.identifier.uri | http://riull.ull.es/xmlui/handle/915/38876 | |
dc.description.abstract | Elevated production of collagen-rich extracellular matrix is a hallmark of cancer-associated fibroblasts (CAFs) and a central driver of cancer aggressiveness. Here we find that proline, a highly abundant amino acid in collagen proteins, is newly synthesized from glutamine in CAFs to make tumour collagen in breast cancer xenografts. PYCR1 is a key enzyme for proline synthesis and highly expressed in the stroma of breast cancer patients and in CAFs. Reducing PYCR1 levels in CAFs is sufficient to reduce tumour collagen production, tumour growth and metastatic spread in vivo and cancer cell proliferation in vitro. Both collagen and glutamine-derived proline synthesis in CAFs are epigenetically upregulated by increased pyruvate dehydrogenase-derived acetyl-CoA levels. PYCR1 is a cancer cell vulnerability and potential target for therapy; therefore, our work provides evidence that targeting PYCR1 may have the additional benefit of halting the production of a pro-tumorigenic extracellular matrix. Our work unveils new roles for CAF metabolism to support pro-tumorigenic collagen production. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | en | |
dc.relation.ispartofseries | Nature Metabolism, Vol. 4, June 2022 | |
dc.rights | Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional) | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES | |
dc.title | Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1038/s42255-022-00582-0 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
DBIOQ. Bioquímica, Microbiología, Biología Celular y Genética
Documentos de investigación (artículos, libros, capítulos de libros, ponencias...) publicados por investigadores del Departamento de Bioquímica, Microbiología, Biología Celular y Genéica